Literature DB >> 18171242

Reversible posterior leukoencephalopathy syndrome in 2 HIV-infected patients receiving antiretroviral therapy.

Anna Lisa Ridolfo1, Federico Resta, Laura Milazzo, Ilaria Caramma, Giovanni Matacena, Spinello Antinori, Massimo Galli.   

Abstract

We describe 2 human immunodeficiency virus-infected patients who developed hypertension and severe neurological abnormalities while receiving successful antiretroviral therapy. Neuroimaging findings were characteristic of reversible posterior leukoencephalopathy syndrome, a brain-capillary leak syndrome with hypertension and endothelial damage. We discuss the role of antiretroviral therapy-associated metabolic alterations in endothelial damage, hypertension, and reversible posterior leukoencephalopathy syndrome.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18171242     DOI： 10.1086/524740

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  The posterior reversible encephalopathy syndrome in HIV infection.

Authors:  Sam Nightingale; Chris Wood; Jonathan Ainsworth
Journal:  BMJ Case Rep       Date:  2012-06-25

2.  Recurrent HIV-associated posterior reversible encephalopathy syndrome.

Authors:  Shaun Zhai; Craig McColl; Aakash Mahajan; Christian J Lueck; Bruce J Brew
Journal:  Neurol Clin Pract       Date:  2019-12

3.  Rare posterior reversible encephalopathy syndrome in a patient with HIV.

Authors:  Sofia Ribeiro; Marta Monteiro; Bruno Moreira; Margarida França
Journal:  BMJ Case Rep       Date:  2013-11-19

4.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Tacrolimus associated posterior reversible encephalopathy syndrome - a case series and review.

Authors:  Susmitha Apuri; Kristin Carlin; Edward Bass; Phuong Thuy Nguyen; John N Greene
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-18       Impact factor: 2.576

6.  Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?

Authors:  Barbara Birner; Cédric Hirzel; Franca Wagner; Gabriel Waldegg
Journal:  BMJ Case Rep       Date:  2018-01-04

7.  Posterior reversible encephalopathy syndrome in a patient with HIV/AIDS and immune reconstitution syndrome: a case study and literature review.

Authors:  Zoe F Weiss; Josiah Rich; Edward J Wing
Journal:  Oxf Med Case Reports       Date:  2018-08-20

8.  Bilateral Visual Loss as Presenting Symptom of Posterior Reversible Encephalopathy Syndrome in a Patient with HIV/Tuberculosis Coinfection: A Case Report.

Authors:  S Guerriero; L Ciracì; T Centoducati; F Pignatelli; V Lamargese; A Salvati; F Dicuonzo
Journal:  Case Rep Ophthalmol Med       Date:  2012-12-03

9.  Posterior Reversible Encephalopathy Syndrome in a Patient with Newly Diagnosed HIV Infection and End Stage Renal Disease.

Authors:  Mohankumar Kurukumbi; Maria I Castellanos; Amanda K Crawford; Shreyas D Gowdar; Annapurni Jayam-Trouth
Journal:  Case Rep Neurol Med       Date:  2013-04-30

10.  Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report.

Authors:  Sarah C Sasson; Aileen Oon; Joga Chagantri; Bruce J Brew; Andrew Carr
Journal:  BMC Infect Dis       Date:  2013-08-28       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.